IRD
Opus Genetics
IRD
IRD
36 hedge funds and large institutions have $5.61M invested in Opus Genetics in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.16% more ownership
Funds ownership: 8.35% → 8.51% (+0.16%)
35% less call options, than puts
Call options by funds: $26K | Put options by funds: $40K
Holders
36
Holding in Top 10
–
Calls
$26K
Puts
$40K
Top Buyers
| 1 | +$1.74M | |
| 2 | +$312K | |
| 3 | +$288K | |
| 4 |
Goldman Sachs
New York
|
+$197K |
| 5 |
BlackRock
New York
|
+$169K |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$413K | |
| 3 | -$334K | |
| 4 |
Millennium Management
New York
|
-$74K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$13K |